Low dose dinaciclib enhances doxorubicin‑induced senescence in myeloma RPMI8226 cells by transformation of the p21 and p16 pathways

Hailong Tang(Xijing Hospital), Guangxun Gao(Xijing Hospital)

Oncology Letters

September 20, 2018

10.3892/ol.2018.9474

Cited by 12

Related Papers

Exosome-transmitted circCABIN1 promotes temozolomide resistance in glioblastoma via sustaining ErbB downstream signaling

|Journal of Nanobiotechnology|2023|38

Isorhapontigenin (ISO) inhibited cell transformation by inducing G0/G1 phase arrest via increasing MKP-1 mRNA stability

|Oncotarget|2014|28

Kill two birds with one stone: Engineered exosome-mediated delivery of cholesterol modified YY1-siRNA enhances chemoradiotherapy sensitivity of glioblastoma

|Frontiers in Pharmacology|2022|25

Chromosome 1q21 gain is an adverse prognostic factor for newly diagnosed multiple myeloma patients treated with bortezomib-based regimens

|Frontiers in Oncology|2022|10